pioglitazone

Generic: pioglitazone

Labeler: direct rx
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pioglitazone
Generic Name pioglitazone
Labeler direct rx
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pioglitazone hydrochloride 30 mg/1

Manufacturer
DIRECT RX

Identifiers & Regulatory

Product NDC 72189-105
Product ID 72189-105_2be8ed92-afbe-9ea7-e063-6294a90a5fcb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA200268
Listing Expiration 2026-12-31
Marketing Start 2020-06-12

Pharmacologic Class

Classes
peroxisome proliferator receptor alpha agonist [epc] peroxisome proliferator receptor gamma agonist [epc] peroxisome proliferator-activated receptor alpha agonists [moa] peroxisome proliferator-activated receptor gamma agonists [moa] thiazolidinedione [epc] thiazolidinediones [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72189105
Hyphenated Format 72189-105

Supplemental Identifiers

RxCUI
312440
UNII
JQT35NPK6C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pioglitazone (source: ndc)
Generic Name pioglitazone (source: ndc)
Application Number ANDA200268 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 30 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE (72189-105-90)
source: ndc

Packages (1)

Ingredients (1)

pioglitazone hydrochloride (30 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2be8ed92-afbe-9ea7-e063-6294a90a5fcb", "openfda": {"unii": ["JQT35NPK6C"], "rxcui": ["312440"], "spl_set_id": ["a7e8d5a3-b0da-1d70-e053-2a95a90aa435"], "manufacturer_name": ["DIRECT RX"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (72189-105-90)", "package_ndc": "72189-105-90", "marketing_start_date": "20200612"}], "brand_name": "PIOGLITAZONE", "product_id": "72189-105_2be8ed92-afbe-9ea7-e063-6294a90a5fcb", "dosage_form": "TABLET", "pharm_class": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]", "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "72189-105", "generic_name": "PIOGLITAZONE", "labeler_name": "DIRECT RX", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PIOGLITAZONE", "active_ingredients": [{"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA200268", "marketing_category": "ANDA", "marketing_start_date": "20200612", "listing_expiration_date": "20261231"}